4729-18-01 Office-based opioid treatment - definitions.

(A) As used in this chapter:

(1) "Controlled substance" has the same meaning as in section 3719.01 of the Revised Code.

(2) "Hospital" means a hospital registered with the department of health under section 3701.07 of the Revised Code.

(3) "Office-based opioid treatment" means the treatment of opioid dependence or addiction using a controlled substance.

(4) "Patient limit" means the maximum number of individual patients that a prescriber may dispense or prescribe a schedule III, IV, or V controlled substance narcotic for the treatment of opioid dependence or addiction at any one time. A patient counts towards a prescriber's patient limit until the controlled substance prescription for the treatment of opioid dependence or addiction has expired or the timeframe in which the medication quantity should have been depleted in accordance with prescription instructions has elapsed.

(5) "Terminal distributor of dangerous drugs with an office-based opioid treatment classification" means a facility, clinic, or other location licensed as a category III terminal distributor where a prescriber provides office-based opioid treatment to more than thirty patients at any one time. It does not include the following:

(a) A hospital;

(b) A facility for the treatment of opioid dependence or addiction that is operated by a hospital;

(c) A physician practice owned or controlled, in whole or in part, by a hospital or by an entity that owns or controls, in whole or in part, one or more hospitals;

(d) A facility that conducts only clinical research and uses controlled substances in studies approved by a hospital based institutional review board or an institutional review board that is accredited by the association for the accreditation of human research protection programs, inc.;

(e) A facility that holds a category III terminal distributor of dangerous drugs license in accordance with section 4729.54 of the Revised Code for the purpose of treating drug dependence or addiction as part of an opioid treatment program and is the subject of a current, valid certification from the substance abuse and mental health services administration of the United States department of health and human services pursuant to 42 C.F.R. 8.11 (12/05/2016); or

(f) A program or facility that is licensed or certified by the department of mental health and addiction services under Chapter 5119. of the Revised Code.

Effective: 5/12/2017
Five Year Review (FYR) Dates: 05/10/2022
Promulgated Under: 119.03
Statutory Authority: 4729.26, 4729.553
Rule Amplifies: 4729.51, 4729.54, 4729.55 , 4729.541